Berenberg Bank set a €92.10 ($107.09) target price on Fresenius Medical Care AG & Co. KGaA (ETR:FME) in a report released on Wednesday morning. The firm currently has a buy rating on the stock.

Several other brokerages have also recently weighed in on FME. Oddo Securities set a €95.00 ($110.47) price objective on Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a report on Monday, June 12th. Jefferies Group LLC set a €85.00 ($98.84) price objective on Fresenius Medical Care AG & Co. KGaA and gave the company a neutral rating in a report on Friday, June 16th. Deutsche Bank AG set a €87.00 ($101.16) price objective on Fresenius Medical Care AG & Co. KGaA and gave the company a neutral rating in a report on Tuesday, April 25th. UBS AG set a €68.00 ($79.07) price objective on Fresenius Medical Care AG & Co. KGaA and gave the company a sell rating in a report on Wednesday, May 3rd. Finally, Independent Research GmbH set a €90.00 ($104.65) price objective on Fresenius Medical Care AG & Co. KGaA and gave the company a neutral rating in a report on Wednesday, May 3rd. Two analysts have rated the stock with a sell rating, ten have assigned a hold rating and eleven have given a buy rating to the company. The company presently has a consensus rating of Hold and a consensus price target of €87.98 ($102.30).

Fresenius Medical Care AG & Co. KGaA (FME) opened at 80.479 on Wednesday. Fresenius Medical Care AG & Co. KGaA has a 1-year low of €70.82 and a 1-year high of €89.07. The firm’s 50-day moving average price is €85.14 and its 200 day moving average price is €80.97. The firm has a market capitalization of €24.65 billion and a price-to-earnings ratio of 19.648.

COPYRIGHT VIOLATION NOTICE: This news story was posted by Watch List News and is owned by of Watch List News. If you are accessing this news story on another site, it was copied illegally and republished in violation of United States & international copyright & trademark laws. The correct version of this news story can be viewed at https://www.watchlistnews.com/berenberg-bank-reiterates-92-10-price-target-for-fresenius-medical-care-ag-co-kgaa-fme/1461957.html.

Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co KGaA is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company’s segments include North America Segment, the Europe, Middle East and Africa (EMEA) Segment, the Asia-Pacific Segment and the Latin America Segment.

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with Analyst Ratings Network's FREE daily email newsletter.